Steward Partners Investment Advisory’s iRadimed IRMD Stock Holding History

Steward Partners Investment Advisory’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18	Closed	-$1.28K	–	4396
2025 Q3	$1.28K	Hold	18	–	–	﹤0.01%	4017
2025 Q2	$1.08K	Hold	18	–	–	﹤0.01%	3846
2025 Q1	$945	Hold	18	–	–	﹤0.01%	3782
2024 Q4	$990	Buy	+18	New	+$947	﹤0.01%	3752
2020 Q2	–	Sell	-57	Closed	-$1K	–	2703
2020 Q1	$1K	Buy	+57	New	+$1.36K	﹤0.01%	2387

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Steward Partners Investment Advisory's IRMD Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of iRadimed (IRMD) in Q4 2025, closing a stake of 18 shares — an estimated $1.28K sold.

Steward Partners Investment Advisory first reported a position in IRMD in Q1 2020 and held it in 5 quarters. The position peaked at $1.28K in Q3 2025. 217 funds tracked by Wall St. Rank hold IRMD as of Q4 2025.

Steward Partners Investment Advisory reported no remaining iRadimed position as of Q4 2025 after selling out during the quarter.
Steward Partners Investment Advisory sold 18 iRadimed shares in Q4 2025, an estimated $1.28K.
Steward Partners Investment Advisory first reported a position in iRadimed in Q1 2020 and held it in 5 quarters.
Steward Partners Investment Advisory's iRadimed position peaked at $1.28K in Q3 2025.
217 funds tracked by Wall St. Rank held iRadimed as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.